2 - TI Pharma

16. Hoes jN, jacobs jW, Verstappen SM, Bijlsma jW, Van der Heijden Gj. Adverse events of low- to
medium-dose oral glucocorticoids in inflammatory diseases: a meta analysis. Ann Rheum Dis.
2009;68(12):1833-8.
17. Tushuizen ME, Bunck MC, Pouwels Pj, Bontemps S, van Waesberghe jH, Schindhelm RK, Mari A,
Heine Rj, Diamant M. Pancreatic fat content and beta-cell function in men with and without type 2
diabetes. 2007. Diabetes Care;30(3):2916-21.
18. Tushuizen ME, Pouwels Pj, Bontemps S, Rustemeijer C, Matikanen N, Heine Rj, Taskinen MR,
Diamant M. Postprandial lipid and apolipoprotein responses following three consecutive meals
associate with liver fat content in type 2 diabetes and the metabolic syndrome. Atherosclerosis.
2010;211(1): 308-14.
19. van Raalte DH, Nofrate V, Bunck MC, van Iersel T, Elassaiss Schaap j, Nassander UK, Heine Rj, Mari
A, Dokter WH, Diamant M. Acute and 2-week exposure to prednisolone impair different aspects of
beta-cell function in healthy men. Eur j Endocrinol. 2010;162(4):729-35.
20. Ackermans MT, Ruiter AF, Endert E. Determination of glycerol concentrations and glycerol isotopic
enrichments in human plasma by gas chromatography/mass spectrometry. Anal Biochem.
1998;258(1):80-6.
21. Ackermans MT, Pereira Arias AM, Bisschop PH, Endert E, Sauerwein HP, Romijn JA. The quantification
of gluconeogenesis in healthy men by (2)H2O and [2-(13)C] glycerol yields different results: rates
of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-
(13)C]glycerol. j Clin Endocrinol Metab. 2001;86(5):2220-6.
22. Geukers VG, Oudshoorn jH, Taminiau jA, van der Ent CK, Schilte P, Ruiter AF, Ackermans MT, Endert
E, jonkers-Schuitema CF, Heymans HS, Sauerwein HP. Short-term protein intake and stimulation of
protein synthesis in stunted children with cystic fibrosis. Am J Clin Nutr. 2005;81(3):605-10.
23. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during
hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous
glucose infusates. Diabetes. 1987;36(8):914-24.
24. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY
Acad Sci. 1959;82:420-30.
25. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. j Appl Physiol.
1983;55(2):628-34.
26. Clore jN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469-74.
27. Corpeleijn E, Saris WH, Blaak EE. Metabolic flexibility in the development of insulin resistance and
type 2 diabetes: effects of lifestyle. Obes Rev. 2009;10(2):178-193.
28. Henriksen jE, Alford F, Vaag A, Handberg A, Beck-Nielsen H. Intracellular skeletal muscle glucose
metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type
2 diabetic patients. Metabolism. 1999;48(9):1128-35.
167
8
Chapter 8